The U.S. FDA on July 15 cleared Biocon Biologics Ltd.’s Kirsty (insulin aspart-xjhz) as the first and only interchangeable biosimilar product referencing Novo Nordisk A/S’ Novolog (insulin aspart), a ...

Kirsty is biosimiler to Novolog. It is a rapid-acting human insulin analog indicated to improve glycemic control in adults ...

The shares of the prominent pharmaceutical company gained up to 4 percent in today's trading session after the company ...

The U.S. Food and Drug Administration has given the green light to Bravecto Quantum, the first-ever flea and tick ...

FDA Approves a ‘Game-Changing’ Twice-a-Year HIV Prevention Shot Yeztugo (lenacapavir) is more than 99.9 percent effective at protecting at-risk people from HIV — but for many, accessing the ...

The US Food and Drug Administration has approved a new system for nerve repair based on light-activated polymers rather than surgical stitches. The flexible polymer system was developed by the ...

The approval of lenacapavir, a form of pre-exposure prophylaxis (PrEP), marks significant progress in preventing HIV, making it vital for the treatment to be available and accessible to those most ...

The FDA has approved Yeztugo (lenacapvir), a twice-yearly injection to prevent HIV infection that could improve adherence rates compared to other PrEP medications and with minimal side effects.

Bristol Myers (BMY) receives FDA approval for label updates for Breyanzi and Abecma, that can ease access to the cancer cell therapies. Read more here.

Recent data indicate that FDA's median time between application submission and approval letter for priority review drugs is just over 8 months, accounting for the filing period.

Clinical trials have shown that six-monthly injections of lenacapavir are almost 100 percent protective against becoming infected with HIV. But big questions remain over the drug’s affordability.

Schrödinger, Inc. (NASDAQ:SDGR) announced that its investigational drug SGR-1505 has received Fast Track designation from the U.S. Food and Drug Administration (FDA) for the treatment of adults ...